Rubric Capital Management LP - Jan 1, 2024 Form 3 Insider Report for Mereo Biopharma Group plc (MREO)

Role
10%+ Owner
Signature
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
Stock symbol
MREO
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/2/2024, 04:00 PM
Previous filing
Nov 17, 2023
Next filing
Jun 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MREO Ordinary Shares, GBP 0.003 par value per share 32M Jan 1, 2024 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MREO American Depositary Shares ("ADSs") Jan 1, 2024 Ordinary Shares 67.8M $0.00 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each ADS represents five (5) Ordinary Shares.
F2 This Form 3 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.